首页> 外文期刊>Transplantation Proceedings >How long should we follow the post-transplantation patient after graft loss? A case report of renal cancer in the grafted kidney that occurred 16 years after graft loss
【24h】

How long should we follow the post-transplantation patient after graft loss? A case report of renal cancer in the grafted kidney that occurred 16 years after graft loss

机译:移植物丢失后,我们应随访多长时间?移植肾丢失16年后发生的移植肾肾癌病例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Background Renal cancers commonly occur in the native kidneys of renal transplant recipients, whereas renal cancer in the grafted kidney has been reported occasionally. Renal cancer in the grafted kidney occurred 16 years after graft loss in this case, which would be a more rare case. Case Report A 60-year-old man who had a kidney transplant from his mother at the age of 31 years and had hemodialysis again because of chronic rejection from the age of 44 years had right lower abdominal pain. Computerized tomography (CT) showed tumor involvement in the grafted kidney. Positron-emission tomography-CT also showed hot spots in the liver, cervical vertebra, and costal bone. Needle biopsy for grafted kidney and liver tumors were done, and pathologic findings revealed renal cancer of grafted kidney and metastatic liver tumor. Graftectomy was done, and renal cancer was diagnosed as spindle cell carcinoma. Irradiation for cervical bone metastasis was done after the surgery. He complained of abdominal pain and eating disturbance 2 months after the surgery. CT showed a huge recurrence tumor and multiple tumor dissemination. Small intestine was involved and obstructed by the main tumor. He died of recurrence of renal cancer 3 months after the surgery. Conclusions It is reported that the rate of renal cell carcinoma in the grafted kidney was 0.19%-0.5% and it occurred at a mean of 12.6 years after renal transplantation. Herein, we report a rare case of renal cancer that occurred 29 years after renal transplantation. Long-term observation should be required for recipients who had rehemodialysis.
机译:背景技术肾癌通常发生在肾移植接受者的天然肾脏中,而移植肾中的肾癌偶有报道。在这种情况下,移植肾的肾癌发生在移植物丢失后16年,这将是更为罕见的情况。病例报告一名60岁男子在31岁时从母亲那里进行了肾脏移植,并由于44岁以后的慢性排斥反应再次进行了血液透析,右下腹疼痛。计算机断层扫描(CT)显示肿瘤累及移植肾。正电子发射断层扫描CT也显示肝脏,颈椎和肋骨中有热点。进行了移植肾和肝肿瘤的穿刺活检,病理结果显示了移植肾和转移性肝肿瘤的肾癌。进行了移植手术,并将肾癌诊断为梭形细胞癌。手术后进行宫颈骨转移放疗。手术后两个月,他抱怨腹部疼痛和饮食失调。 CT显示巨大的复发性肿瘤和多发性肿瘤。小肠受累于主要肿瘤并被其阻塞。他在手术后三个月死于肾癌复发。结论据报道,移植肾中肾细胞癌的发生率为0.19%-0.5%,平均发生在肾移植后12。6年。在此,我们报道了肾脏移植后29年发生的罕见肾脏癌病例。接受血液透析的接受者应进行长期观察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号